Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China.
Eur J Dermatol
; 30(6): 738-740, 2020 Dec 01.
Article
in English
| MEDLINE | ID: covidwho-1067482
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Psoriasis
/
Biological Products
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
/
Young adult
Country/Region as subject:
Asia
Language:
English
Journal:
Eur J Dermatol
Journal subject:
Dermatology
Year:
2020
Document Type:
Article
Affiliation country:
Ejd.2020.3908
Similar
MEDLINE
...
LILACS
LIS